The End Tuberculosis Now Act of 2026 authorizes the U.S. government to provide foreign assistance to combat tuberculosis globally through prevention, diagnosis, and treatment programs. The legislation sets ambitious goals for the period 2027-2030, including reducing TB incidence by 80 percent and mortality by 90 percent from 2015 levels, diagnosing and treating 90 percent of TB cases, and providing preventive treatment to 30 million individuals worldwide. The bill prioritizes support for countries with the highest TB burden, innovative diagnostic tools, treatment of drug-resistant TB strains, healthcare worker training, and coordination with international partners and the private sector. The legislation requires annual reports to Congress through 2032 detailing the number of individuals diagnosed and treated, spending breakdowns by country and project site, and progress toward the stated goals. The bill's provisions automatically expire on January 1, 2033, unless Congress takes action to extend them.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.